NCT04155840 2022-04-11Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaUniversity of WashingtonPhase 2 Terminated1 enrolled 6 charts